Delta Asset Management’s Biogen BIIB Stock Holding History

Delta Asset Management’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$18.3K	Hold	100	–	–	﹤0.01%	386
2025 Q4	$17.6K	Hold	100	–	–	﹤0.01%	385
2025 Q3	$14K	Hold	100	–	–	﹤0.01%	407
2025 Q2	$12.6K	Hold	100	–	–	﹤0.01%	416
2025 Q1	$13.7K	Hold	100	–	–	﹤0.01%	399
2024 Q4	$15.3K	Hold	100	–	–	﹤0.01%	395
2024 Q3	$19.4K	Hold	100	–	–	﹤0.01%	376
2024 Q2	$23.2K	Hold	100	–	–	﹤0.01%	338
2024 Q1	$21.6K	Hold	100	–	–	﹤0.01%	358
2023 Q4	$25.9K	Hold	100	–	–	﹤0.01%	329
2023 Q3	$25.7K	Hold	100	–	–	﹤0.01%	324
2023 Q2	$28.5K	Hold	100	–	–	﹤0.01%	319
2023 Q1	$27.8K	Hold	100	–	–	﹤0.01%	300
2022 Q4	$27.7K	Buy	+100	New	+$28.2K	﹤0.01%	290
2022 Q1	–	Sell	-100	Closed	-$24K	–	192
2021 Q4	$24K	Hold	100	–	–	﹤0.01%	327
2021 Q3	$28K	Hold	100	–	–	﹤0.01%	303
2021 Q2	$35K	Hold	100	–	–	﹤0.01%	275
2021 Q1	$28K	Hold	100	–	–	﹤0.01%	296
2020 Q4	$24K	Hold	100	–	–	﹤0.01%	316
2020 Q3	$28K	Hold	100	–	–	﹤0.01%	280
2020 Q2	$27K	Sell	100 -9	-8%	-$2.71K	﹤0.01%	286
2020 Q1	$34K	Hold	109	–	–	0.01%	247
2019 Q4	$32K	Hold	109	–	–	﹤0.01%	289
2019 Q3	$25K	Hold	109	–	–	﹤0.01%	302
2019 Q2	$25K	Hold	109	–	–	﹤0.01%	282
2019 Q1	$26K	Hold	109	–	–	﹤0.01%	272
2018 Q4	$33K	Hold	109	–	–	0.01%	275
2018 Q3	$39K	Hold	109	–	–	0.01%	277
2018 Q2	$32K	Hold	109	–	–	﹤0.01%	291
2018 Q1	$30K	Hold	109	–	–	﹤0.01%	297
2017 Q4	$35K	Hold	109	–	–	﹤0.01%	287
2017 Q3	$34K	Hold	109	–	–	0.01%	265
2017 Q2	$30K	Hold	109	–	–	﹤0.01%	272
2017 Q1	$30K	Buy	109 +9	+9%	+$2.54K	﹤0.01%	278
2016 Q4	$28K	Hold	100	–	–	﹤0.01%	291
2016 Q3	$31K	Hold	100	–	–	0.01%	274
2016 Q2	$24K	Hold	100	–	–	﹤0.01%	304
2016 Q1	$26K	Hold	100	–	–	﹤0.01%	296
2015 Q4	$31K	Hold	100	–	–	0.01%	268
2015 Q3	$29K	Hold	100	–	–	0.01%	272
2015 Q2	$40K	Hold	100	–	–	0.01%	243
2015 Q1	$42K	Hold	100	–	–	0.01%	244
2014 Q4	$34K	Hold	100	–	–	0.01%	279
2014 Q3	$33K	Hold	100	–	–	0.01%	273
2014 Q2	$32K	Hold	100	–	–	0.01%	276
2014 Q1	$31K	Hold	100	–	–	0.01%	273
2013 Q4	$28K	Hold	100	–	–	0.01%	281
2013 Q3	$24K	Hold	100	–	–	0.01%	299
2013 Q2	$22K	Buy	+100	New	+$21.4K	0.01%	308

Other funds holding BIIB

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Delta Asset Management's BIIB Position: Q1 2026 in Review

Delta Asset Management held its Biogen (BIIB) position steady in Q1 2026 at 100 shares worth $18.3K. The position accounts for ﹤0.01% of the portfolio, ranked #386.

Delta Asset Management first reported a position in BIIB in Q2 2013 and has held it in 49 quarters since. The position peaked at $42K in Q1 2015. 1,002 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.

Delta Asset Management held 100 shares of Biogen worth $18.3K as of Q1 2026.
Delta Asset Management left its Biogen share count unchanged in Q1 2026.
Biogen made up ﹤0.01% of Delta Asset Management's portfolio in Q1 2026, its #386 holding.
Delta Asset Management first reported a position in Biogen in Q2 2013 and has held it in 49 quarters since.
Delta Asset Management's Biogen position peaked at $42K in Q1 2015.
1,002 funds tracked by Wall St. Rank held Biogen as of Q1 2026.

Based on Delta Asset Management's 13F filing for Q1 2026, filed 11 May 2026.